Cite

HARVARD Citation

    Farkas, K. et al. (n.d.). DOP13 Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjects. Journal of Crohn's and colitis. pp. i73-i76. [Online]. 
  
Back to record